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ABSTRACT: Bacteria utilize the tightly regulated stress response (SOS) pathway to respond to a variety of genotoxic agents,
including antimicrobials. Activation of the SOS response is regulated by a key repressor-protease, LexA, which undergoes
autoproteolysis in the setting of stress, resulting in derepression of SOS genes. Remarkably, genetic inactivation of LexA’s self-
cleavage activity significantly decreases acquired antibiotic resistance in infection models and renders bacteria hypersensitive to
traditional antibiotics, suggesting that a mechanistic study of LexA could help inform its viability as a novel target for combating
acquired drug resistance. Despite structural insights into LexA, a detailed knowledge of the enzyme’s protease specificity is
lacking. Here, we employ saturation and positional scanning mutagenesis on LexA’s internal cleavage region to analyze >140
mutants and generate a comprehensive specificity profile of LexA from the human pathogen Pseudomonas aeruginosa (LexAPa).
We find that the LexAPa active site possesses a unique mode of substrate recognition. Positions P1−P3 prefer small hydrophobic
residues that suggest specific contacts with the active site, while positions P5 and P1′ show a preference for flexible glycine
residues that may facilitate the conformational change that permits autoproteolysis. We further show that stabilizing the β-turn
within the cleavage region enhances LexA autoproteolytic activity. Finally, we identify permissive positions flanking the scissile
bond (P4 and P2′) that are tolerant to extensive mutagenesis. Our studies shed light on the active site architecture of the LexA
autoprotease and provide insights that may inform the design of probes of the SOS pathway.
In an era of rising drug resistance and a diminishing pipelinefor new antibiotics, understanding the mechanisms that drive
acquired drug resistance in bacteria has become critical.
Bacterial adaptation and evolution are closely tied to the stress
response (SOS) pathway, a widely conserved, inducible
network of genes involved in DNA repair and recombination
that allows bacteria to respond to DNA damage. The SOS
response is governed by a bifunctional repressor-protease,
LexA. In its basal state, LexA represses the transcription of 15−
40 genes involved in the SOS response (Figure 1A).
Interactions with RecA, a sensor of DNA damage, cause
LexA to self-cleave (autoproteolyze), resulting in the
derepression of the downstream SOS genes.1−4 These induced
SOS genes include Y-family DNA polymerases, which catalyze
error-prone translesional replication over damaged DNA and
can promote acquired drug resistance.5,6 Further, LexA
autoproteolysis increases the level of expression of integrons
involved in the transfer of mobile genetic elements and has
been associated with the formation of biofilms.7,8 Thus, LexA
and the SOS pathway regulate several of the major mechanisms
by which pathogens can tolerate antimicrobials and acquire
drug resistance.
The LexA repressor was the notable first of a family of
enzymes shown to undergo self-cleavage as part of their
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physiological function.9−15 Members of this family possess a
conserved serine-lysine catalytic dyad that cleaves between an
Ala-Gly or Cys-Gly sequence within the protease domain.12 In
its repressor role, LexA functions as a dimer, with each
monomer containing an N-terminal DNA binding domain
(NTD) that is connected by a flexible linker to the C-terminal
serine protease domain (CTD) (Figure 1B).16 Structural
studies of Escherichia coli LexA have shown that the CTD can
exist in two distinct conformations, and that self-cleavage is
associated with a shift from a basal cleavage-incompetent
conformation of the CTD to a cleavage-proficient conforma-
tion.12,16 Self-cleavage is initiated when LexA is exposed to
either activated RecA (RecA*) in vivo and in vitro or high pH in
vitro, features shared by several other members of the LexA
superfamily.9−11,17,18
The cleavage-proficient conformation of LexA has several
unique features. The protein loop containing the scissile Ala-
Gly bond appears to form specific contacts near the active site,
suggesting that like classical serine proteases, there is a binding
pocket involved in cleavage sequence recognition.12 Indeed,
genetic mutagenesis and selection studies of LexA and the
related λ CI repressor have indicated that point mutations at
several of the residues surrounding the cleavage loop can
interfere with self-cleavage.19−21 However, in conventional
serine proteases, the scissile bond of the substrate peptide is
almost uniformly bound in the middle of an extended β-sheet.
In LexA, by contrast, the bond is positioned at the end of a β-
turn.12,22−24 Furthermore, because LexA acts upon a tethered
substrate (the cleavage region within the same molecule), the
effective local concentration of the substrate is high. This
feature may explain why common serine protease inhibitors,
such as diisopropyl fluorophosphate, inhibit LexA only at
extremely high concentrations, and why wild-type LexA only
weakly cleaves peptides or other proteins in trans.18,25 This
distinctive binding mode and requirement for a conformational
change for catalysis make LexA a potentially distinctive
therapeutic target among proteases.
Genetic and synthetic biology studies have shown that
preventing LexA autoproteolysis decreases the rate of develop-
ment of resistance and can sensitize bacteria to antibiotics.
Most notably, when an E. coli strain harboring a noncleavable
mutant of LexA was evaluated in a murine infection model, the
development of antibiotic resistance was abrogated by the loss
of normal LexA function.26 Specifically, while the wild-type
bacteria thrived and became entirely resistant to rifampin after
drug exposure in the mouse model, the mutant strain failed to
acquire any rifampin resistance. In an alternative study, phage-
mediated transduction of E. coli with an inactivated LexA
protease was shown to greatly hypersensitize the bacteria to
traditional antibiotics.27 In addition to participating in the
Figure 1. LexA repressor-protease regulates the bacterial stress response (SOS pathway). (A) Autoproteolysis of the LexA repressor-protease
activates the mutagenic SOS response in bacteria. In the absence of stress, LexA binds to SOS-controlled promoters, limiting their action. When
DNA is damaged, RecA filaments form at the site of damage and stimulate LexA self-cleavage. Autoproteolysis prompts dissociation of LexA from
DNA, permitting expression of downstream SOS genes. Activation of the SOS response and its associated DNA damage tolerance pathways
increases bacterial survival and mutation rates. (B) Structure of LexA from E. coli. LexA binds to DNA as a dimer. The C-terminal domain (CTD)
contains the major dimerization interface and a serine protease active site. The N-terminal domain displays a winged helix−turn−helix motif and
binds to the palindromic DNA of the SOS box. The CTD and NTD are connected by a flexible linker peptide (dashed line), which was not resolved
in the crystal structure (PDB entry 3JSO). The close-up of the LexA CTD active site shows an overlay of the cleavage-competent and cleavage-
incompetent forms of LexA (PDB entries 1JHE and 1JHC, respectively). The internal cleavage loop of LexA undergoes a large conformational
change between the cleavage-incompetent state (red) and the cleavage-competent state (purple), placing a scissile bond in the proximity of the active
site serine-lysine catalytic dyad (red and blue surfaces, respectively). The active site is boxed for the sake of clarity. (C) The LexA cleavage regions
across species from different families of pathogenic bacteria (Gram-negative, Gram-positive, and mycobacteria) are shown. The scissile Ala-Gly bond
is noted (green arrow), and numbering is shown relative to Pseudomonas aeruginosa LexA (LexAPa). The percent identity is represented by the degree
of shading with red and plotted below the alignment.
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transfer of mobile genetic elements, LexA has been suggested to
mediate persister formation and play a role in stress-induced
mutagenesis.7,28,29 Targeting LexA pharmacologically, there-
fore, has been suggested as a means to delay the acquisition of
resistance, increase the efficacy of known antimicrobials, and
offer insight into bacterial adaptation and evolution.26,30,31
Despite the availability of crystal structures of the LexA, a
detailed structure−function relationship of the LexA active site
and the cleavage sequence has yet to be established. Here, we
study the LexA protein from Pseudomonas aeruginosa (LexAPa),
a Gram-negative pathogen that is an archetype for the problem
of acquired drug resistance and a major cause of mortality in
cystic fibrosis patients.32,33 We developed a methodology for
high-efficiency mutagenesis and enzymatic characterization to
profile the substrate preferences of LexA autoproteolysis
comprehensively for the first time. Combined with available
structural data, this study provides insight into the mechanism
of LexA substrate recognition and lays the groundwork for
efforts to develop inhibitors and probes of LexA, the SOS
pathway, and bacterial evolution.
■ EXPERIMENTAL PROCEDURES
LexAPa Cloning and Expression. All oligonucleotide
sequences used in LexAPa amplification, cloning, and cassette
mutagenesis were purchased from Integrated DNA Technolo-
gies (IDT) and are available upon request. The lexA gene was
amplified via polymerase chain reaction with LexAPa genomic
primers from the P. aeruginosa PA01 strain and cloned into the
pET41 expression vector engineered with an N-terminal His
tag and C-terminal Streptavidin tag.34 The S125A active site
mutant was generated by QuikChange site-directed muta-
genesis. The enzyme was heterologously expressed in E. coli,
followed by one-step purification using the N-terminal tag. The
purified product was predominantly full-length (∼26 kDa),
with trace amounts of self-cleavage that occurs during the
course of purification.
Saturation Mutagenesis. For the efficient generation of
saturation and positional scanning mutagenesis variants,
mutations introducing the unique restriction sites AgeI and
Eagl were engineered at nucleotide positions 255 and 282,
respectively, in the lexA coding sequence using QuikChange
site-directed mutagenesis. An additional mutation (BamHI) at
nucleotide 267 and a TAG stop were included within the
cassette region, as mechanisms for selection against wild-type
sequences from the parent vector. This construct served as the
parent cloning vector for cassette-based mutagenesis. Briefly,
the LexAPa cloning vector was digested with AgeI, BamHI, and
EagI for 2 h at 37 °C and treated with calf intestinal
phosphatase. Individual oligonucleotides containing a degener-
ate codon (NNS) at each position from position 85 to 94 were
ordered from IDT and annealed to their complement with a
standard annealing protocol. Annealed oligonucleotides con-
taining sticky ends complementary to AgeI and EagI cleavage
sites were phosphorylated with T4 polynucleotide kinase for 1
h at 37 °C. The oligonucleotide cassettes were ligated into the
digested cloning vector using T4 DNA ligase. The ligation
product was then transformed into New England Biolabs
(NEB) 10-β competent cells using standard transformation
procedures. One-tenth of the transformation mixture was
plated to estimate the library size, and the remaining portion
was grown overnight in Luria-Bertani broth. The isolated
plasmids from this culture constituted the saturation muta-
genesis library at each position (I85X, G86X, etc.). Successful
incorporation of the degenerate NNS codon was verified by
Sanger sequencing of the library.
Point Mutations of Selected Residues in the LexAPa
Cleavage Loop. The same cassette-based mutagenesis
strategy was adopted to generate the individual point mutations
in residues spanning positions P5 to P2′ of the LexAPa cleavage
region (residues 86−92). For each of the seven positions, 20
forward and reverse oligonucleotides encoding each amino acid
mutation were constructed and ordered from IDT. Oligonu-
cleotides containing two mutant codons were used for the
LexAPa A89C/I94C double mutant. Oligonucleotide pairs were
annealed, phosphorylated, and ligated into the digested parent
vector, as described above. After transformation, individual
colonies were selected and mutant plasmids were sequenced to
confirm the proper insertion of the mutation cassettes.
Expression and Purification of LexAPa, Saturation
Mutant Cohorts, or Individual Positional Scanning
Mutants. Expression plasmids were transformed into BL21-
(DE3)-pLysS E. coli cells for heterologous expression. For the
saturation mutant library, the liquid culture after transformation
was used as the starter overnight culture. For point mutants, the
transformation was plated and an individual colony selected for
the starter overnight culture. The following day, 35 mL Luria-
Bertani broth cultures were inoculated with 1 mL of overnight
culture and grown at 37 °C until the OD600 reached ∼0.6. The
cultures were subsequently induced with 1 mM isopropyl β-D-
1-thiogalactopyranoside, shifted to 30 °C, and grown for 4 h.
The culture was centrifuged at 4000 rpm for 20 min at 4 °C
and the pellet stored at −80 °C until it was purified. Thawed
cell pellets were lysed per protocol with Bugbuster Mastermix
(Novagen). The soluble supernatant was incubated with 100
μL of reconstituted HisPur resin (Pierce) for batch binding at 4
°C for 1 h in 10 mL polyprep columns (Bio-Rad). The flow-
through was discarded and the resin subsequently washed three
times with 10 resin volumes of wash buffer [25 mM sodium
phosphate (pH 7.0), 150 mM NaCl, and 30 mM imidazole].
Following the wash, bound protein was eluted from the resin
with 3 resin volumes of elution buffer [25 mM sodium
phosphate (pH 7.0), 150 mM NaCl, and 200 mM imidazole].
The eluted proteins were then dialyzed into 25 mM Tris-HCl
(pH 7.0), 150 mM NaCl, and 10% glycerol. The same protocol
was used for the wild-type enzyme, saturation mutant libraries,
and individual positional scanning mutants. For the 140
positional scanning mutants (20 amino acids × 7 positions),
the cohorts of 20 mutants at each position were processed in
parallel to provide an internal (wild-type) control.
Alkali-Mediated Qualitative Cleavage Assays of
LexAPa. To qualitatively screen the cleavage ability of LexAPa
variants, purified protein was mixed in a 1:1 ratio with 2×
cleavage buffer (100 mM Tris-Glycine-CAPS and 300 mM
NaCl) at pH 7.2 or 10.6. Reaction mixtures were incubated at
room temperature for 16 h. Cleavage was quenched by adding
2× Laemmli sample buffer to the reaction mixture and by
denaturation at 95 °C for 10 min. The extent of LexAPa
cleavage was visualized by running reaction samples on 15%
sodium dodecyl sulfate−polyacrylamide gel electrophoresis
(SDS−PAGE) gels and Coomassie staining. Mutants that
displayed cleavage were selected for further quantitative
analysis. Coomassie-stained gels were imaged on a Typhoon
Imager using red laser excitation at 633 nm and no filters. The
fraction of cleaved protein was calculated by dividing the
density of the LexAPa cleavage products by the sum of the
density of all LexAPa full-length and cleaved components, using
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Quantity One (Bio-Rad). Linear detection of Coomassie-
stained products was verified by analysis of standards.
RecA*-Mediated Cleavage of LexAPa Proteins. RecA of
E. coli was purchased from NEB. Purified LexAPa was incubated
with an excess of activated RecA*, generated by premixing
∼100 μg/mL RecA, 900 μM ATPγS, and 10 μM ssDNA.35
Reactions without RecA were run parallel as a negative control.
Reaction mixtures were incubated at room temperature for 16
h. The cleavage products were analyzed and quantified as
described for alkali-mediated cleavage.
Alkali-Mediated Quantitative Assays of LexAPa. For
quantitative kinetic analysis, 25 μL of purified protein was
mixed with 25 μL of 2× cleavage buffer (pH 10.6) and the
mixture incubated at 37 °C for 2 h. At the given time points, 5
μL of the reaction mixture was removed and the reaction
rapidly quenched in 2× Laemmli sample buffer. The extent of
cleavage over time was visualized on Coomassie-stained 15%
SDS−PAGE gels. For restrictive positions, time points were
collected in triplicate, while reactions were run in duplicate for
the permissive positions. Coomassie-stained gels were imaged
and quantified as detailed above.
Calculation of LexAPa Cleavage Rates and Generation
of the LexAPa Cleavage Profile. The density of the protein
bands was quantified using Quantity One (Bio-Rad). For each
time point, the fraction of uncleaved LexAPa was calculated as
described above and plotted versus time. Rate plots were then
fit to the first-order exponential decay equation A = A0e
−kt using
Prism to obtain k, the observed rate of cleavage. To calculate
the specificity profile, we used the enoLOGOS web tool to
generate a normalized sequence LOGO of the P5−P2′
sequence preferences.36 The cleavage rate constants, k, at
each position were used as the relative scaling factors, with an
unknown weight type and the frequency method for calculating
the height of the symbol stacks.
Structural Modeling of LexAPa. To assist with the analysis
of our biochemical data, we generated a structural model of the
LexAPa CTD. We entered the amino acid sequence of the
LexAPa CTD (residues 81−204) into Modeler 2.0,37 with the
crystal structure of activated LexA from E. coli as the homology
template (PDB entry 1JHE).12
Liquid Chromatography and Tandem Mass Spec-
trometry (LC−MS/MS). LC−MS/MS was performed at the
Proteomics & Systems Biology Core Facility at the University
of Pennsylvania Perelman School of Medicine. Purified LexAPa
A89C/I94C samples were either reduced or not reduced with 1
M dithiothreitol and treated with 300 mM iodoacetamide
(molecular mass of 57 Da). Samples were subsequently
digested with trypsin and subjected to LC−MS/MS. Peptide
fragments were identified and analyzed with PEAKS.38
■ RESULTS
The Sequence of LexAPa Is Strongly Identical to That
of LexA of E. coli. The LexA protein is strongly conserved
across all families of bacteria and shares a high level of sequence
similarity.9−15 Given the importance of drug resistance in the
opportunistic pathogen P. aeruginosa, we focused our efforts on
studying the LexA of P. aeruginosa (LexAPa). A sequence
alignment of LexAPa with LexA of E. coli (LexAEc) reveals a 64%
sequence identity, with notable features such as the serine-
lysine catalytic dyad and the internal cleavage loop conserved
(Figure S1A of the Supporting Information). This strong
sequence identity provided the basis for structural modeling of
the LexAPa CTD to help interpret our biochemical assays
(Figure S2 of the Supporting Information). We modeled
LexAPa based on the structure of the CTD of LexAEc in the
active conformation (PDB entry 1JHE), with the high degree of
sequence homology resulting in a root-mean-square deviation
of 1.2 Å between the known and modeled structures.
Saturation Mutagenesis of LexAPa Reveals the
Tolerance of Residues in the LexA Cleavage Region to
Mutation. We next cloned, expressed, and purified LexA from
reference strain PA01. In accordance with prior biochemical
assays on LexA from other species, we demonstrated that our
tagged LexAPa is proficient in both alkali- and RecA*-mediated
autoproteolysis (Figure S3 of the Supporting Information).
Recombinant LexAPa displayed cleavage kinetics similar to that
of tagged or untagged LexA from other species (see
below).18,39−42
Prior biochemical studies have revealed that the LexA
protease has poor cleavage activity in trans.18,25 In its wild-type
catalytic form, both the full-length LexA protein and the
isolated LexA protease domain are unable to efficiently cleave
the target substrate of a second LexA enzyme.18 Extensive
mutagenesis of the enzyme’s active site and the target sequence
can allow for trace detectable activity in trans; however, it is
clear that the native substrate of LexA is itself.18 We explored
the possibility that full-length LexA or the CTD alone may
cleave short peptides that mimic the internal cleavage loop;
however, we did not observe cleavage in fluorescence- or LC−
MS-based cleavage assays (data not shown). For these reasons,
conventional peptide array-, genetic library-, and mass
spectrometry-based methods for assessing protease specificity
could not be readily translated to characterizing LexAPa
specificity.43−47 We therefore decided to directly assess
LexA’s specificity by exhaustive mutagenesis of the cleavage
loop within the enzyme and assessing (in cis) autoproteolysis
activity. Given that this approach would require extensive
mutagenesis, we implemented an efficient cassette mutagenesis
strategy for introducing variations into the internal substrate of
LexA (Figure S4 of the Supporting Information).48−50 The
specificity determinants of LexAPa could be delineated broadly
at first by saturation mutagenesis (the introduction of a
degenerate codon) and then in detail by positional scanning
mutagenesis (the generation of individual point mutants to
each of the 20 amino acids).
For saturation mutagenesis, 10 duplexed oligonucleotide
cassettes that contain a degenerate NNS codon at each position
from Ile85 to Ile94 (e.g., I85X) were produced. The degenerate
NNS codon encodes all 20 potential amino acid variants and
one potential stop codon (TAG). The calculated depth of the
library at each position was >1000-fold, and the presence of a
degenerate NNS codon at each position was verified by
sequencing. Although this library is not proportionally
represented for the various amino acid substitutions, we
reasoned that the general patterns of restrictive and permissive
positions could be gleaned from analysis of a positionally
diversified cohort of variants.
For each position, we expressed and purified the mutant
protein library in cohort, which showed expression character-
istics and solubility similar to those of wild-type LexAPa. Each
cohort was then incubated overnight at pH 7.2 or 10.6, and the
fraction of cleavage was assessed under these conditions
(Figure 2). The positions clustered into two general groups
based upon comparison to wild-type LexAPa: positions P5
(G86), P3 (V88), P2 (A89), P1 (A90), and P1′ (G91) appear
to be restrictive to mutation, displaying small changes in the
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fraction of cleaved protein (<30%), while the remaining
positions were more permissive to the introduction of a
degenerate codon, exhibiting changes in cleavage levels closer
to that of the wild-type enzyme despite being highly diversified
(Figure 2). We repeated the analysis in the presence or absence
of RecA* and found the same overall patterns of tolerant and
restrictive positions with this alternative stimulus for
autoproteolysis (Figure S5 of the Supporting Information).
Notably, as RecA*-mediated cleavage analysis was used as a
purely qualitative measure, we used RecA from E. coli in our
assays (74% identical and 87% similar to that of P. aeruginosa)
because of its availability and the observation that LexAPa
cleaves as efficiently as LexAEc under RecA* stimulation.
Positional Scanning Mutagenesis and a Cleavage
Screen of Residues P5−P2′ Identify Specific Residues
That Are Important for LexAPa Autoproteolysis. The
qualitative overview from saturation mutagenesis set the stage
for detailed quantitative analysis. Here, we focused on the
residues of positions P5−P2′, spanning the most restrictive
sites we identified by saturation mutagenesis. Furthermore, the
LexAPa homology model suggests that these residues form the
most extensive interactions with the surrounding active site
pocket (Figure S2 of the Supporting Information).
In our positional scanning mutagenesis approach, for each
position of interest, we individually mutated the residues to
each of the 20 potential amino acids (G86A, G86S, G86T, etc.)
using cassette mutagenesis. For each position, all 20 variants
were expressed, purified in parallel and subjected to both alkali-
and RecA*-mediated cleavage overnight to identify specific
variants that permitted autoproteolysis (Figure S6 of the
Supporting Information). Together, the individual point
mutants in this assay validated the patterns observed with
saturation mutagenesis. The full cleavage profiles for each
position are provided in Figure S6 of the Supporting
Information, with select examples of a restrictive and tolerant
position shown in Figure 3. Restrictive positions, such as P1
(A90), tolerate only a few mutations, while permissive
positions, such as P4 (R87), tolerated all amino acids, although
to varying degrees (Figure 3). Both alkali- and RecA*-mediated
cleavage screens yielded similar cleavage results, with the
exception of position P5, where RecA*-mediated cleavage was
more restrictive than alkali-mediated cleavage (Figure S6A of
the Supporting Information). Overall, the cleavage behavior of
select restrictive mutations in LexAPa (G86V, G86D, V88M,
V88E, A89V, A90D, and A90T) agrees qualitatively with the
results of a prior study of LexA from E. coli that identified slow-
cleaving variants via limited mutagenesis and genetic screen-
ing.51 One notable exception is the aspartate mutation at the
P1′ glycine, which completely abrogates alkali-mediated and
RecA*-mediated cleavage in LexAPa (Figure S6F of the
Supporting Information) but allows limited levels of cleavage
in LexA from E. coli.51
Kinetic Evaluation of Cleavable Mutants. Individual
mutants deemed cleavage-proficient under overnight cleavage
conditions were next subjected to detailed kinetic analysis. We
performed the cleavage reaction under alkali-induced con-
ditions to allow for direct comparison of the various mutants.
Alkali-mediated cleavage, while nonphysiological, has the
distinctive advantage of being a unimolecular first-order
reaction, allowing us to probe the intrinsic substrate preferences
of LexAPa without confounders such as potential alterations in
RecA* interactions (Table 1). Employing our method, we
determined the rate of autoproteolysis of all cleavable mutants.
Representative data from one highly restrictive (P1) position
and one tolerant position (P4) are presented in panels C and D
of Figure 3, with kinetic plots for all cleavable variants shown in
Figure S7 of the Supporting Information. Notably, the rate of
cleavage of the wild-type enzyme at each position differed
slightly (range of 53−144 × 10−5 s−1) as a result of batch-to-
batch variability in expression and purification. Given that each
cohort of 20 mutants at a position was prepared in parallel, the
rate of each mutant was scaled to that of the wild type to obtain
the relative amino acid preferences, with the comprehensive
analysis summarized (Figure 4A).
The positions upstream of the cleavage site show an
alternating pattern of being restrictive or permissive to
variation, with restrictive positions favoring the wild-type
residue over all other amino acids. At position P5 (G86), we
see a modest tolerance for amino acids with either a small or
flexible side chain, such as A or S, while larger side chains
reduce the level of LexAPa self-cleavage (Figure 4B). Position
P4 (R87), which appears solvent-exposed in the LexAPa model,
shows tolerance to all variants, despite being conserved as a
basic residue across species (Figure 1C). Indeed, certain acidic
or large hydrophobic variants such as R87E and R87W appear
to cleave at rates higher than that of the wild-type enzyme.
Position P3 (V88) is restrictive, with the wild-type residue
preferred 5-fold over the next best variant, V88I. Three of the
four best variants are the β-branched amino acids, suggesting
the possibility of active site engagement with the branched side
chains. Other tolerated variants are hydrophobic and
Figure 2. Saturation mutagenesis of the LexAPa cleavage region. For
each position from I85 to I94, the wild-type codon was substituted
with a degenerate NNS codon. To determine the tolerance for
mutation at each position qualitatively, the saturation mutant library at
each position was purified as a cohort and subjected to overnight self-
cleavage at pH 7.2 (L) or pH 10.6 (H). Self-cleavage of the full-length
(FL) enzyme results in the generation of the isolated C-terminal and
N-terminal domains (CTD and NTD, respectively). The multiple
banding in the lower-molecular weight fragments is caused by the
migration patterns of mutants with an altered charge state. The
fraction of cleavage product detected under each condition is shown
(pH 7.2, gray columns; pH 10.6, black columns). Error bars represent
the standard error of duplicate trials.
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predominantly small amino acids. Position P2 (A89), exposed
in the active conformation of LexAPa, tolerates all amino acids,
although to different extents. Variants with the smallest side
chains (A89G, wild type with A89, and A89S) are most readily
cleaved, while the level of cleavage generally decreases as a
function of increasing size.
The positions immediately flanking the cleavage site show
highly restrictive patterns, while preferences are again relaxed in
the downstream positions. At position P1 (A90), only the five
smallest amino acids are tolerated: the wild-type A90 is
preferred over the next best variant A90G by 4-fold, while
cleavage is detectable with A90C, A90S, and A90T, suggesting
significant active site constraints at this position. Position P1′
Figure 3. Positional scanning mutagenesis and kinetic analysis of the LexAPa cleavage region. Each residue from G85 to A92 was mutated to each of
the 20 amino acids. Each point mutant was expressed and purified separately. Shown are the results from overnight cleavage at pH 7.2 (L) or pH
10.6 (H) for each mutant of (A) A90 (position P1), a relatively restrictive position, or (B) R87 (position P4), a relatively tolerant position. The wild-
type enzyme is denoted by WT. Cleavable mutants of (C) A90 (position P1) or (D) R87 (position P4) from the initial cleavage screen were then
evaluated for their alkali-stimulated cleavage kinetics. The data represent three replicates for restrictive (P1) positions and two replicates for tolerant
(P4) positions. For the sake of clarity, the kinetic data for five of the 20 R87 variants representing varying cleavage rates are shown. The points are fit
as a first-order exponential decay, and the standard error is shown. Mutants are grouped by the properties of their side chains at physiological pH
(orange for hydrophobic, purple for aromatic, yellow for hydrophilic, green for positive charge, and blue for negative charge). The wild-type (WT)
residue is indicated with a thicker dotted line. Corresponding results for all positions from P5 to P2′ are displayed in Figures S6 and S7 of the
Supporting Information, with quantitative results for rates listed in Table 1.
Table 1. First-Order Rate Constants for Alkali-Induced Self-Cleavage of LexAPa Mutants
rate, k (×10−5 s−1)
P5 P4 P3 P2 P1 P1′ P2′
amino acid mutation G86 R87 V88 A89 A90 G91 A92
G 76 ± 13 23 ± 2 3.2 ± 0.2 113 ± 8 38 ± 2 144 ± 3 26 ± 2
A 25 ± 2 143 ± 10 10.5 ± 0.8 98 ± 3 157 ± 10 - 95 ± 13
S 11 ± 1 85 ± 10 0.5 ± 0.1 121 ± 8 2.0 ± 0.3 2.8 ± 0.3 50 ± 3
C 3.8 ± 0.3 63 ± 10 5.5 ± 0.5 4.0 ± 0.5 2.3 ± 0.2 − 105 ± 10
T 2.8 ± 0.3 130 ± 17 8.7 ± 0.5 3.0 ± 0.5 1.0 ± 0.2 − 53 ± 7
D 7.8 ± 0.2 63 ± 7 − 2.2 ± 0.3 − − 27 ± 2
P − 103 ± 12 − 3.2 ± 0.5 − − 433 ± 150
N 15.8 ± 0.3 45 ± 8 − 6.5 ± 0.5 − − 137 ± 12
V 0.5 ± 0.2 113 ± 20 76 ± 7 1.0 ± 0.1 − − 62 ± 5
E 3.8 ± 0.1 183 ± 33 − 2.2 ± 0.3 − − 85 ± 8
Q 2.5 ± 0.2 100 ± 17 − 5.5 ± 0.8 − − 167 ± 20
H 7.3 ± 0.2 25 ± 5 − 5.2 ± 1.2 − − 85 ± 7
L 0.5 ± 0.2 45 ± 7 0.16 ± 0.01 4.8 ± 0.3 − − 73 ± 5
I 7.8 ± 0.2 50 ± 8 15.2 ± 0.7 2.2 ± 0.2 − − 125 ± 12
M 11 ± 2 60 ± 7 0.3 ± 0.1 2.2 ± 1.2 − − 65 ± 5
K 6.0 ± 0.2 78 ± 10 − 1.3 ± 0.3 − − 103 ± 10
F 5.8 ± 0.3 68 ± 10 − 6.8 ± 1.0 − − 75 ± 12
Y 6.5 ± 0.3 210 ± 45 − 9.0 ± 1.3 − − 65 ± 5
R 3.2 ± 0.2 53 ± 3 − 4.7 ± 0.2 − − 77 ± 13
W 5.5 ± 0.2 216 ± 12 − 25 ± 3 − − 113 ± 15
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(G91) is situated at the β-turn of the LexA cleavage region in its
active conformation. It is the most restrictive position among
those examined, with only a serine mutation retaining any
detectable self-cleavage activity (∼50-fold slower than the WT).
Position P2′ (A92) is a solvent-exposed residue and situated at
the end of the β-turn. The tolerance of this position to
mutation is in line with its poor conservation across species
isoforms of LexA (Figure 1C).
The kinetic data determined at each position allow for the
construction of the overall sequence preference heat map for
LexAPa (Figure 4A). The calculated cleavage rates were used to
build the position-specific scoring matrix, which was then
graphically converted into a sequence LOGO depiction that
encapsulates the substrate specificity profile for LexAPa (Figure
4B). As evidenced in the sequence LOGO, positions tolerant to
mutation have high entropy or variability, while restrictive
positions show low variability.
Kinetic Analysis Reveals LexAPa Mutants That Cleave
Faster than the Wild-Type Enzyme. In our kinetic assays of
the LexAPa mutants, we observed that certain mutants
interestingly exhibited a cleavage rate higher than that of the
wild-type enzyme (“hyperactive” mutants). While some hyper-
active mutants of LexA have previously been discovered
through genetic screens,52,53 the molecular basis for hyperactive
self-cleavage has not been well-investigated. In our mutagenesis,
A92P shows a notable cleavage rate ∼4-fold higher than that of
the wild-type enzyme and undergoes autoproteolysis even
under nonstimulatory conditions (neutral pH, no RecA*)
(Table 1 and Figure S6G of the Supporting Information). The
transition between the cleavage-incompetent and cleavage-
competent forms of LexA is associated with a β-turn at the
cleavage site (A90-G91).12 Because position A92 is located at
the end of the β-turn in the LexA cleavage loop, we
hypothesized that a mutation to proline stabilizes the β-turn
and could thereby promote the active conformation of the
protein.54,55 To test this hypothesis, we introduced cysteine
mutations at positions A89 and I94, two residues that are
within disulfide bonding distance in the active conformation
(Figure S2 of the Supporting Information). We then confirmed
by mass spectrometry that the variant formed an intramolecular
disulfide bond across the β-turn (Figure S8 of the Supporting
Information). While the individual point mutants have rates of
cleavage slower than (A89C) or comparable to (I94C) that of
the wild type, the A89C/I94C double mutant is enhanced, in
line with the A92P cleavage rate (Figure 5). While the
mechanism cannot be definitively assessed, the A92P and
A89C/I94C LexA variants point to the importance of
secondary structure formation in the cleavage region, with
potential implications for inhibitor design.
■ DISCUSSION
The emergence of drug resistance in bacterial pathogens is one
of the most pressing issues in infectious diseases today,
particularly given the limited pipeline of new antimicrobials to
combat this threat.56,57 Given the need for a better mechanistic
understanding of bacterial adaptation and novel approaches to
combating drug resistance, the idea of targeting the pathways
that allow bacterial pathogens to adapt and evolve resistance to
Figure 4. Substrate preference for alkali-mediated self-cleavage of
LexAPa. (A) Heat map representing the cleavage rates of the LexAPa
point mutants. The wild-type residues from position P5 to P2′ are
listed along the top. The rows represent each point mutation, listed in
order of the increasing size of the amino acid. Crosses denote
analogues that show no cleavage in the overnight self-cleavage assay at
pH 10.6. For each cleavable analogue, the first-order rate constant for
self-cleavage was determined at pH 10.6 [two or three replicates per
condition (Table 1)]. The rate for each mutant was scaled relative to
the wild-type residue and shown in the heat map as shades from white
to blue. Residues that cleave at rates greater than that of the wild type
are colored deep blue. (B) Normalized sequence LOGO diagram
summarizing the autoproteolysis profile of LexAPa. The diagram was
generated using the enoLOGOS program with the rates of cleavage at
each position as the relative scaling factors. The color scheme groups
amino acids as in Figure 3.
Figure 5. Stabilizing the β-turn around the LexAPa scissile bond
enhances autoproteolysis. (A) Time-dependent cleavage profiles of
LexAPa wild type (WT), A92P, and A89C/I94C. Proteins were
incubated at pH 10.6, quenched at the given time points, and
visualized using SDS−PAGE. (B) Cleavage kinetics of hyperactive
variants and controls with individual mutants to cysteine. In triplicate,
the fraction of uncleaved protein was determined using densitometry
and fit as a function of time according to first-order decay kinetics.
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antibiotics has been proposed.26,30 In support of this approach,
stimulating genetic and synthetic biologic studies have
suggested that targeting LexA autoproteolysis can prevent
activation of the SOS pathway and thereby hypersensitize
bacteria to traditional antibiotics, slow acquired drug resistance,
and offer insights into the mechanisms driving bacterial
evolution. To inform our understanding of LexA, we performed
exhaustive mutagenesis studies on >140 variants of LexA that
help to delineate the key determinants of proteolysis. These
studies have led us to conclude that the LexA repressor-
protease possesses a unique substrate preference, with both
side-chain and conformational requirements that govern
autoproteolysis. Dissecting each of these stringent, intermedi-
ate, and tolerant determinants for self-cleavage offers insights
into LexA’s mechanism (Figure 6) and can fuel future efforts to
probe the SOS pathway.
Stringent Determinants: Positions P3, P1, and P1′. We
have identified three positions in the LexA cleavage region that
are restrictive to extensive mutation. Interestingly, although
exhaustive mutagenesis was not performed, point mutations at
these positions were also identified to be important for the self-
cleavage of the related λ CI repressor, and the positions are well
conserved in LexA isoforms across species (Figure 1C).21 For
LexAPa, positions P3 and P1 favor the wild-type residues and
show tolerance toward β-branched or small amino acids,
respectively. For both positions, analysis of the crystal structure
shows extensive van der Waals contacts between the side chains
and hydrophobic pockets in the LexA active site (Figure 6B).
Because increasing or decreasing the size of the amino acid at
these positions reduces cleavage efficiency (Table 1), we
conclude that positions P3 and P1 determine specificity
through active site contacts.
Position P1′ is the most restrictive position, tolerating only
the wild-type glycine and a serine mutation. Position P1′ is
located at the end of the β-hairpin turn and undergoes a
dramatic bond rotation during the transition between active
and inactive conformations.12 Only glycine can readily adopt
and interconvert between these unusual Ramachandran angles,
thus explaining the strong preference for the wild-type residue
at that position. Larger amino acids likely cause steric clash with
the surrounding protein or are hindered in making the
necessary bond rotations. Interestingly, trace cleavage was
also detectable in the G91S mutant (Figure S6F of the
Supporting Information). We speculate that mutation to a
serine likely allows for the formation of hydrogen bonds
between the side-chain hydroxyl group and peptide backbone
that can stabilize the turn, compensating for the decreased level
of rotational freedom.
Intermediate Determinants: Positions P5 and P2.
Unlike the stringent determinants, positions P5 and P2 tolerate
a wide range of mutations yet display a preference for a
particular subset of amino acids. At position P5, the wild-type
residue, glycine, is preferred over a larger amino acid, such as
alanine or serine. Similar to position P1′, in the determined
structures of LexA, the glycine at position P5 undergoes a
significant rotation during the transition from the inactive state
to the active state, thus explaining the presence of a flexible
residue that can serve as a molecular hinge.12
Position P2 displays an intermediate phenotype, as well:
although all variants are tolerated, amino acids that exceed the
size of serine decrease the rate of self-cleavage. Structurally, the
side chain of position P2 forms contacts with the side chain of
position P4′ (I94) located on the opposite side of the loop
(Figure S2 of the Supporting Information). Increasing the size
of the amino acid likely reduces the rate of cleavage due to
steric clash.
Permissive Positions and Enhanced Autoproteolysis:
Positions P4 and P2′. In addition to deciphering specificity
determinants, our study has also identified two highly
permissive positions that flank the LexA scissile bond. Positions
P4 and P2′ can be mutated to the whole amino acid spectrum
without abrogating LexA cleavage, although changes in the rate
of cleavage are observed. The LexAPa model structure shows
both positions to be relatively solvent-exposed, forming few
specific contacts with the surrounding active site. Interestingly,
both positions also harbor mutations that enhance the level of
self-cleavage compared to that of the wild-type enzyme. At
position P4 (R87), mutations removing a basic residue appear
Figure 6. Postulated structure−function relationship of the key
residues in the LexAPa cleavage region. (A) Structural model
demonstrating intermediate, stringent, and tolerant positions in the
active LexAPa cleavage region. This active site model is taken from the
full homology model of the LexAPa CTD described in Figure S2 of the
Supporting Information. Positions evaluated in this study are shown as
sticks and color-coded according to their selectivity (red, stringent;
orange, intermediate; green, tolerant). Other residues in the LexA
cleavage region are shown as pink lines. The LexAPa catalytic serine
S125 and basic lysine K162 are shaded red and blue, respectively,
highlighting the active site. (B) Interactions between the LexAPa
cleavage loop and LexAPa active site pocket. For each position from
position P5 to P2′, the active site residues (S5−S2′) within van der
Waals contact range of the side chain are noted in the box. Positions
P3 (V88) and P1 (A90) form specific hydrophobic contacts with the
surrounding active site, which are conserved in both LexAPa and
LexAEc. Position P2 (A89) interacts with position P4′ (I94) on the
opposite side of the loop turn. At each of these positions, the wild-type
residues and smaller side chains are more conducive to proteolysis.
The two flanking glycines, G86 and G91 (P5 and P1′, respectively),
show a preference for the wild-type glycine, which may confer
rotational flexibility on the LexA cleavage region, allowing the internal
loop to undergo the transition from the inactive form to the active
form. Positions P4 (R87) and P2′ (A92), which are notably solvent-
exposed, are tolerant to all amino acid substitutions, including several
that can enhance cleavage.
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to enhance self-cleavage (Table 1), despite the conservation of
the basic residue in LexA across species (Figure 1C). We
speculate that these rate-enhancing mutations may result from
the removal of a potential repulsive interaction with an adjacent
(and well-conserved) positively charged residue (R120) in the
active conformation. Position P2′, in contrast to position P4, is
highly variable across species (Figure 1C), which correlates well
with its tolerance to mutagenesis in our biochemical study. At
position P2′, introduction of a proline mutation enhances self-
cleavage, likely by stabilizing the β-turn around the scissile bond
and thereby promoting the cleavage-competent state of LexA.
This model is supported by our analysis of the disulfide cross-
linked A89C/I94C mutant, which shows cleavage kinetics
similar to those of the A92P mutant (Figure 5B).
Our results expand the list of previously identified mutations
that enhance LexA cleavage.52 In a prior study, mutations
located at positions P5′ and P8′ in E. coli LexA, distant from the
catalytic site, were shown to stabilize the active conformation of
the entire LexA cleavage loop.12,52 Our results for A92P and
A89C/I94C mutants suggest that stabilizing the β-turn around
the scissile bond with rigid cyclic structures similarly enhances
cleavage and could offer novel avenues for inhibitor design.
Conformational Constraints and Side-Chain Recog-
nition in LexA. The nature of our experimental design, which
focused on mutations in the cleavage loop and kinetic analysis
of autoproteolysis, requires that the enzyme and its substrate
change simultaneously. Additionally, given that we evaluated
single-point mutants, the impact of combinatorial modifications
in the substrate could not be readily assessed from our
approach. Despite these limitations, the relative independence
of the cleavage loop and the active site residues make it possible
to integrate across our biochemical analysis and structural
modeling to provide a detailed picture of LexA’s specificity.
From our analysis, we postulate that the nature of the specificity
determinants of LexA can be classified under two broad
categories: those permissive for substrate recognition and those
permissive for the conformational change in self-cleavage
(Figure 6B). Much like conventional proteases, LexA has
substrate recognition pockets that determine its selectivity,
most evident at positions P3 (V88) and P1 (A90) (Figure 6B).
As a key difference from conventional proteases, however, the
LexA cleavage region must internally rearrange to adopt a
proper cleavage-competent conformation for proteolysis to
occur. Positions P5 (G85) and P1′ (G91) are highly dynamic
positions, implying that conformational flexibility at either end
of the cleavage region appears to be important for
autoproteolysis. In support of the importance of dynamic
rearrangements in LexA, stabilizing the β-turn across the scissile
bond promotes self-cleavage at a level above that of the wild
type. We postulate that these requirements for both proper
sequence and conformation serve as a mechanism of self-
recognition and limit off-target proteolytic activity. Our findings
help rationalize the low cleavage activity of the LexA protease in
trans and offer insights into rational probe design.18
Comparison of LexAPa to Similar Proteases. Our
biochemical results are particularly informative when we
compare LexAPa to members of the larger LexA/signal
peptidase superfamily, many of which mediate bacterial stress
responses (Figure S1B of the Supporting Information). This
superfamily includes LexA homologues such as Bacillus subtilis
DinR and Vibrio cholerae SetR, the phage λ CI repressor, and
UmuD and MucA, self-cleaving enzymes that function in the
SOS-linked translesion DNA synthesis.11,13,17,18,21,41,58,59 In
these enzymes, position P1′ is universally conserved as a glycine
(Figure S1 of the Supporting Information), suggesting that the
flexibility of position P1′ is likely critical to the mechanism. The
stringent residues involved in side-chain contacts are also
strongly conserved, with a β-branched residue at position P3
and a small residue at position P1 conserved across
comparators (Figure S1B of the Supporting Information).
Notably, the position S3 and S1 recognition pockets are
entirely conserved between LexAPa and LexAEc (Figure S1A of
the Supporting Information), suggesting a common mechanism
of side-chain recognition in forms of LexA from different
species. For the intermediate determinants, the position P5
glycine offers the most revealing comparison to other self-
cleaving enzymes. We speculate that this residue is a critical
“hinge” for the conformational change that allows self-cleavage
within a LexA monomer. Interestingly, position P5 is not
conserved in UmuD where cleavage of one monomer can occur
in the other monomer’s active site.9 Overall, comparing the
superfamily to other common serine proteases, we note that
LexA favors small amino acids in the positions flanking the
scissile bond, most similar to the elastase family of serine
proteases.23,24 However, the unique self-cleaving mechanism
and its conformational requirements are distinguishing features
that appear to be well conserved across the LexA/signal
peptidase superfamily.
Implications for the Design of Inhibitors and
Molecular Probes of LexA. In addition to revealing insights
into the mechanism of self-cleavage, several aspects of our
substrate specificity studies can potentially help direct future
efforts to develop small molecule probes of the SOS pathway.
First, while LexA does not have proficient activity with peptides
in trans, it does have detectable activity. Peptides or
peptidomimetics that incorporate preferred features, such as
the side chains of positions P3 and P1 or β-turn-stabilizing
structures, may be exploited to enhance binding. Even weak
binding peptides or peptidomimetics could be converted into
more potent probes by the incorporation of mechanism-based
covalent inhibitor warheads into such molecules. Second, our
discovery of tolerance at positions P4 and P2′ could be
exploited in inhibitor discovery. The introduction of fluorescent
reporters at these positions could aid in screening for inhibitors
of self-cleavage or, given the highly dynamic nature of position
P2′, potential allosteric modulators of the conformational
change. Finally, our discovery of a range of hypocleavable LexA
variants can potentially help further validate LexA’s viability as a
therapeutic target. Given that LexA inhibitors would be unlikely
to fully recapitulate the LexA catalytic mutant, these variants
can be used to reveal the amount of inhibition that will be
necessary to synergize with current antibiotics or to slow
acquired antibiotic resistance.
Implications for Bacterial Mutation and Evolution. We
hypothesize that the identification of rate-enhancing mutations
by prior genetic studies and our biochemical studies has wider
implications for bacterial mutagenesis and evolution.52,53 The
fact that mutations can enhance cleavage suggests the
possibility that the rate of LexA autoproteolysis may be finely
tuned to be fast enough to facilitate robust SOS responses but
slow enough to prevent aberrant SOS pathway activation. This
characteristic has been thought to be functionally important in
different members of the LexA superfamily. As an example,
temperate phage repressors such as the phage λ CI repressor
self-cleave more slowly than LexA during SOS-inducing
treatments, thereby inducing prophage formation only with
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extensive DNA damage.18 Similarly, mutagenesis proteins, such
as UmuD, self-cleave at rates slower than that of LexA, which
could promote translesion DNA synthesis later in the SOS
response, only after higher-fidelity repair mechanisms have
failed.17 Given that self-cleavage can be either slowed or
enhanced by mutations, we hypothesize that the LexA cleavage
rate has been selected for to allow for proper activation of the
SOS pathway and that LexA may serve as a rheostat for
evolution under stress. Our study offers the possibility of
modulating the cleavage rates of LexA across a large range to
assess the impact on bacterial mutation and survival directly
under varying degrees of stress.
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